Atherosclerotic Regulation of Asparagus racemosus Root Extract on Lipid Profile in Male Swiss Albino Mice, Subjected to Inorganic Lead Compound

2011 ◽  
Vol 4 (1) ◽  
pp. 107-114
Author(s):  
Veena Sharma ◽  
Ritu Bala Verma ◽  
Shatruhan Sharma
2018 ◽  
Vol 11 (1) ◽  
pp. 40-45
Author(s):  
Sharmila Kameyanda Poonacha ◽  
Satheesh Kumar Bhandary Bavabeedu ◽  
Ronald Fernandes ◽  
Suchetha Kumari Nalilu ◽  
Vadisha Srinivas Bhat ◽  
...  

2020 ◽  
Vol 12 (3) ◽  
pp. 226-230
Author(s):  
Sharmila Kameyanda Poonacha ◽  
Satheesh Kumar Bhandary Bavabeedu ◽  
Suchetha Kumari Nalilu ◽  
Pooja Pooja S ◽  
Vadisha Srinivas Bhat ◽  
...  

Author(s):  
Koech SC ◽  
Ouko RO ◽  
Michael NM ◽  
Ireri MM ◽  
Ngugi MP ◽  
...  

3 Biotech ◽  
2021 ◽  
Vol 11 (6) ◽  
Author(s):  
Mahesh P. Patil ◽  
Jayesh J. Ahire ◽  
Ulhas K. Patil ◽  
Bharat Bhushan ◽  
Bhushan L. Chaudhari

2021 ◽  
Vol 2021 ◽  
pp. 1-6
Author(s):  
Dehnnet Abebe ◽  
Gomathi Periasamy ◽  
Aman Karim ◽  
Helen Bitew

Introduction. Cyphostemma adenocaule (Steud. ex A. Rich) Descoings ex wild & Drummond (Vitaceae) has been used in traditional medicine for the management of various immunological and hematological disorders in different areas of Ethiopia and the rest of the world. In Ethiopia, the plant is used for the management of enlarged spleen, rabies virus, helminthic infection, snake bite, and various types of tumors. Objective. To evaluate the effect of hydroethanolic root extract and solvent fractions of Cyphostemma adenocaule on cell-mediated immunity (delayed-type hypersensitivity), organ index (spleen and liver), and blood cell count in Swiss albino mice. Materials and Methods. Acute oral toxicity test was conducted using nulliparous and nonpregnant Swiss albino mice following OECD 425 limit test method. Delayed-type hypersensitivity model was used to evaluate the effect on cell-mediated immunity. The experimental animals were divided into twelve groups which were sensitized and challenged with sheep red blood cells on day 0 and day 7, respectively. Levamisole 50 mg/kg was used as stimulant control, whereas cyclophosphamide 30 mg/kg was used as suppressant control. Hydroethanolic root extract (100 mg/kg, 200 mg/kg, and 400 mg/kg), aqueous fraction (100 mg/kg, 200 mg/kg, and 400 mg/kg), and n-butanol fraction (100 mg/kg, 200 mg/kg, and 400 mg/kg) were administered for seven days. The paw volume was measured using a digital plethysmometer before challenge and 24 hours after challenge. Blood was collected, and organs (spleen and liver) were isolated from each challenged mouse to determine blood cell count and organ index, respectively. Results. No mortality and noticeable behavioral changes were observed among all mice receiving hydroethanolic root extract and solvent fractions at a dose of 2000 mg/kg. Hydroethanolic root extract and solvent fractions of Cyphostemma adenocaule showed enhancement of delayed-type hypersensitivity, organ index, and blood cell count. Hydroethanolic root extract at a dose of 400 mg/kg showed the highest and statistically significant stimulation of delayed-type hypersensitivity (0.123 ± 0.010) and blood cell count compared to the vehicle. Conclusion. Hydroethanolic root extract and solvent fractions of Cyphostemma adenocaule showed a stimulatory effect on cell-mediated immunity and hematopoiesis.


2018 ◽  
Vol 5 (2) ◽  
Author(s):  
Ragesh R Nair

The aim of the study was to evaluate the acute oral and sub-acute toxicity of ethanolic root extract of Tetracera akara in Swiss albino mice and Wistar rats. Tetracera akara (Burm. f.) Merr. has been used as traditional medicine by the Kani tribe of Kerala to cure liver diseases. In acute toxicity studies, four groups of mice (n = 5/group/sex) were orally treated with doses of 0.625 g, 1.25 g, 2.5 g and 5.0 g/kg and mortality were recorded. In the sub-acute toxicity study, animals received T. akara extract at the doses of 0.1 g, 0.5 g and 2.5 g/kg/day (n = 5/group/sex) for 28 days, biochemical, hematological, morphological and histopathological parameters were determined. T. akara did not produce any mortality in the acute toxicity studies, showing LD50 higher than 5 g/kg. Sub-acute treatment with T. akara didn’t cause any changes in body weight gain, hematological, biochemical profiles when compared to normal control. In addition, no changes in morphological and histopathological aspect of organs were observed in the animals. Taking all factors into consideration, administration of Tetracera akara does not produce acute toxicity in Swiss albino mice or sub-acute toxicity in Wistar rats, suggesting it’s safe use by humans.


Sign in / Sign up

Export Citation Format

Share Document